163 related articles for article (PubMed ID: 15853697)
1. Recent development of peptides from glycoproteins IIb (alphaIIb) and IIIa (beta3) that inhibit platelet fibrinogen binding.
Chiang TM
Curr Med Chem Cardiovasc Hematol Agents; 2005 Apr; 3(2):99-103. PubMed ID: 15853697
[TBL] [Abstract][Full Text] [Related]
2. A defined peptide that inhibits the formation of the glycoprotein IIb and IIIa complex.
Chiang TM; Zhu J
Thromb Res; 2005; 115(6):503-8. PubMed ID: 15792682
[TBL] [Abstract][Full Text] [Related]
3. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH
J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956
[TBL] [Abstract][Full Text] [Related]
4. Ability of different glycoprotein IIb-IIIa ligands to support platelet aggregation induced by activating antibody CRC54.
Naimushin YA; Mazurov AV
Biochemistry (Mosc); 2005 Jul; 70(7):782-9. PubMed ID: 16097942
[TBL] [Abstract][Full Text] [Related]
5. [Variations in glycoprotein IIb-IIIa (alphaIIb/beta3-integrin) content in healthy donors. Influence on platelet aggregation activity and efficacy of aspirin action].
Khaspekova SG; Sirotkina OV; Shimanova IuV; Mazurov AV
Biomed Khim; 2008; 54(3):361-71. PubMed ID: 18712091
[TBL] [Abstract][Full Text] [Related]
6. Effect of synthetic peptides corresponding to residues 313-332 of the alphaIIb subunit on platelet activation and fibrinogen binding to alphaIIbbeta3.
Mitsios JV; Tambaki AP; Abatzis M; Biris N; Sakarellos-Daitsiotis M; Sakarellos C; Soteriadou K; Goudevenos J; Elisaf M; Tsoukatos D; Tsikaris V; Tselepis AD
Eur J Biochem; 2004 Feb; 271(4):855-62. PubMed ID: 14764102
[TBL] [Abstract][Full Text] [Related]
7. Dissociation of glycoprotein IIb/IIIa antagonists from platelets does not result in fibrinogen binding or platelet aggregation.
Frelinger AL; Furman MI; Krueger LA; Barnard MR; Michelson AD
Circulation; 2001 Sep; 104(12):1374-9. PubMed ID: 11560852
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effect of peptide inhibitors derived from the extracellular and intracellular domain of α
Gkourogianni AV; Kiouptsi K; Koloka V; Moussis V; Tsikaris V; Bachelot-Loza C; Tsoukatos DC
Platelets; 2018 Jan; 29(1):34-40. PubMed ID: 28351192
[TBL] [Abstract][Full Text] [Related]
9. Arginyl-glycyl-aspartyl (RGD) epitope of human apolipoprotein (a) inhibits platelet aggregation by antagonizing the IIb subunit of the fibrinogen (GPIIb/IIIa) receptor.
Barre DE
Thromb Res; 2007; 119(5):601-7. PubMed ID: 16860375
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the role of adjacent amino acids to the 313-320 sequence of the alphaIIb subunit on platelet activation and fibrinogen binding to alphaIIbbeta3.
Mitsios JV; Stamos G; Rodis FI; Tsironis LD; Stanica MR; Sakarellos C; Tsoukatos D; Tsikaris V; Tselepis AD
Platelets; 2006 Aug; 17(5):277-82. PubMed ID: 16928597
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa (alphaIIb/beta3) receptor-directed platelet inhibition.
Li YF; Spencer FA; Becker RC
Am Heart J; 2001 Aug; 142(2):204-10. PubMed ID: 11479455
[TBL] [Abstract][Full Text] [Related]
12. Glycoprotein IIb/IIIa inhibitors increase COAT-platelet production in vitro.
Hamilton SF; Miller MW; Thompson CA; Dale GL
J Lab Clin Med; 2004 May; 143(5):320-6. PubMed ID: 15122176
[TBL] [Abstract][Full Text] [Related]
13. Allicin and disulfiram enhance platelet integrin alphaIIbbeta3-fibrinogen binding.
Manaster Y; Shenkman B; Rosenberg N; Savion N
Thromb Res; 2009 Sep; 124(4):477-82. PubMed ID: 19632706
[TBL] [Abstract][Full Text] [Related]
14. Norcantharidin, a clinical used chemotherapeutic agent, acts as a powerful inhibitor by interfering with fibrinogen-integrin α
Hsia CH; Lu WJ; Lin KH; Chou DS; Geraldine P; Jayakuma T; Chang NC; Sheu JR
J Cell Mol Med; 2018 Apr; 22(4):2142-2152. PubMed ID: 29369482
[TBL] [Abstract][Full Text] [Related]
15. The interaction of integrin αIIbβ3 with fibrin occurs through multiple binding sites in the αIIb β-propeller domain.
Podolnikova NP; Yakovlev S; Yakubenko VP; Wang X; Gorkun OV; Ugarova TP
J Biol Chem; 2014 Jan; 289(4):2371-83. PubMed ID: 24338009
[TBL] [Abstract][Full Text] [Related]
16. Structure and function of murine alphaIIbbeta3 (GPIIb/IIIa): studies using monoclonal antibodies and beta3-null mice,
Smyth SS; Tsakiris DA; Scudder LE; Coller BS
Thromb Haemost; 2000 Dec; 84(6):1103-8. PubMed ID: 11154120
[TBL] [Abstract][Full Text] [Related]
17. Mapping the binding domains of the alpha(IIb) subunit. A study performed on the activated form of the platelet integrin alpha(IIb)beta(3).
Biris N; Abatzis M; Mitsios JV; Sakarellos-Daitsiotis M; Sakarellos C; Tsoukatos D; Tselepis AD; Michalis L; Sideris D; Konidou G; Soteriadou K; Tsikaris V
Eur J Biochem; 2003 Sep; 270(18):3760-7. PubMed ID: 12950259
[TBL] [Abstract][Full Text] [Related]
18. Glycoprotein IIb-IIIa-liposomes bind fibrinogen but do not undergo fibrinogen-mediated aggregation.
Sloan SM; Brown EB; Liu Q; Frojmovic MM
Platelets; 2000 Mar; 11(2):99-110. PubMed ID: 10938888
[TBL] [Abstract][Full Text] [Related]
19. Glycoprotein IIb-IIIa content and platelet aggregation in healthy volunteers and patients with acute coronary syndrome.
Yakushkin VV; Zyuryaev IT; Khaspekova SG; Sirotkina OV; Ruda MY; Mazurov AV
Platelets; 2011; 22(4):243-51. PubMed ID: 21329420
[TBL] [Abstract][Full Text] [Related]
20. Platelet glycoprotein IIb/IIIa antagonists: lessons learned from clinical trials and future directions.
Leclerc JR
Crit Care Med; 2002 May; 30(5 Suppl):S332-40. PubMed ID: 12004256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
